Studies on the gene regulatory networks (GRNs) of sea urchin embryos have provided a basic understanding of the molecular mechanisms controlling animal development. The causal links in GRNs have been verified experimentally through perturbation of gene functions. Microinjection of antisense morpholino oligonucleotides (MOs) into the egg is the most widely used approach for gene knockdown in sea urchin embryos. The modification of MOs into a membrane-permeable form (vivo-MOs) has allowed gene knockdown at later developmental stages. Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the clustered regularly interspaced short palindromic repeat/clustered regularly interspaced short palindromic repeat-associated protein 9 (CRISPR/Cas9) system, have provided methods for gene knockout in sea urchins. Here, we review the use of vivo-MOs and genome editing tools in sea urchin studies since the publication of its genome in 2006. Various applications of the CRISPR/Cas9 system and their potential in studying sea urchin development are also discussed. These new tools will provide more sophisticated experimental methods for studying sea urchin development.
Introduction
Sea urchins have been a research model in developmental biology for over a century [1] . In recent decades, studies on the molecular mechanisms controlling the early developmental processes of the embryos have assembled developmental gene regulatory networks (GRNs) that elucidate causal links between regulatory factors and genomic sequences [2, 3] . These regulatory factors, including transcription factors and signaling molecules, are activated initially by asymmetrically distributed or differentially activated maternal factors present in the egg. The hierarchical activation of regulatory factors then leads to the expression of differentiation gene batteries that control cell differentiation, movement and various developmental processes. Functional perturbation of these regulatory factors followed by measurement of the effects on the potential target genes has enabled the establishment of epistatic relationships required for the construction of experimental GRN models.
Several approaches have been used to perturb gene function in sea urchin embryos, including pharmacological treatment, injections of mRNAs encoding dominant-negative forms, morpholino oligonucleotide (MO) injection and, recently, targeted genome editing. Pharmacological treatments are commonly used for interfering with signaling pathways [4] [5] [6] [7] [8] [9] [10] . By directly adding antagonists or agonists into embryo cultures, signaling can be perturbed and precisely controlled during any developmental interval. Notably, most of these drugs target signaling transduction processes elicited by multiple signaling ligands and thus are not best suited for inferring the functions of individual genes. To achieve gene-specific perturbations, dominant-negative mRNA and MOs can be introduced into the embryos via microinjection. Dominant-negative forms of regulatory factors, in which their functional domains are either mutated/deleted or replaced with a repressive domain, are able to compete with the endogenous factors, thus inhibiting their regulatory functions [7, [11] [12] [13] [14] [15] [16] . MOs, which are usually ribonucleotide oligos of 25 bases in length, can be designed to inhibit translation or mRNA splicing by binding to the complementary sequences in transcripts. The knockdown effect mediated by MOs can persist for up to a few days, making MOs a routinely used perturbation agent for constructing GRN models [7, [17] [18] [19] [20] [21] .
Delivery of these gene-specific perturbation reagents is commonly achieved through microinjection in zygotes. Therefore, the perturbations are limited by the scale at which microinjection can be performed, and they lack spatial and temporal control. Regulatory genes are often expressed repeatedly in different cell types during development; the typical perturbation method thus becomes an issue for studying later functions of regulatory factors without interfering with their early roles. Only in recent years has delivery of MOs into sea urchin embryos at later stages become possible. Vivo-MOs, which are modified MOs linked to a molecular transporter with eight guanidinium head groups, have been shown to be effective in penetrating cell membranes [22] . Therefore, vivo-MOs can be added into sea urchin cultures at the chosen developmental stage to achieve stage-specific perturbation [5, 23] .
Recent advances in genome editing technologies have opened an additional avenue for gene-specific perturbation in sea urchin embryos. Three major families of targeted genome editing systems, ZFNs, transcription activator-like effectorbased nucleases (TALENs) and clustered regularly interspaced short palindromic repeat/clustered regularly interspaced short palindromic repeat-associated protein 9 (CRISPR/Cas9), have been applied to disrupt functions of sea urchin genes by introducing mutations into the coding sequences [24] [25] [26] [27] [28] . By targeting the regulatory genome, which is often located in the noncoding regions, these editing techniques also allow researchers to study the 'upstream' control mechanisms of gene expression-a critical aspect for network verification-in its native genomic environment.
In this review, we focus on functional perturbations using vivo-MOs and genome editing techniques, intending to provide a summary of advancement in functional perturbation approaches in sea urchin developmental studies since its genome was published in 2006. The well-established approaches of injecting mRNA and regular MOs have been reviewed elsewhere [21, 29] and are not covered here.
Vivo-antisense MOs
Vivo-MOs contain two functional compartments: a morpholino oligo, ensuring the targeting specificity, and a covalently linked octa-guanidine dendrimer for membrane penetration. As with MOs, vivo-MOs can be designed to block translation, by binding to start codons, or to interfere with mRNA splicing by targeting intron-exon junctions. However, vivo-MOs have not been widely used in sea urchins because of two major limitations. First, the solubility of vivo-MOs in seawater limits the concentrations one can use when vivo-MOs are directly added to sea urchin cultures. To improve the solubility, vivo-MO stock solutions can be incubated at 65 C before being diluted in seawater, and the working solutions are then vortexed thoroughly before mixing with cultures. While solubility is sequence dependent, using vivo-MOs at over 20 mM often results in precipitates in seawater that affect embryogenesis. Second, in our experience, vivo-MOs are generally more toxic than regular MOs. Several tests are recommended for the use of vivo-MOs in sea urchin studies (Supplementary Figure S1) . A pilot toxicity test is used to find concentrations that do not result in severe mortality. Two studies have used vivo-MOs with sequences of regular MOs that are known to be effective in the sea urchin Strongylocentrotus purpuratus [5, 23] . Translation-blocking vivoMOs against nodal and bmp2/4 are effective when directly added to embryo cultures at 5 mM [5] . Vivo-MOs targeting the skeletogenic genes P16 [30] and P58b [31] , by blocking translation and splicing, respectively, are also effective either by addition to cultures at 15 mM or injection into juvenile rudiment tissues at 20 mM in injection solutions [23] .
With the advance of vivo-MOs, functional perturbations at later developmental stages of sea urchins have become feasible. Other approaches for gene knockdowns at later stages include the use of regular MOs with Endo-Porter (GeneTools), a novel peptide that delivers substances into cells through an endocytosis-mediated process [32] , and Photo-MOs that can switch gene expression on or off with light [33] . However, these methods have not been applied in sea urchins, and their effectiveness remains unclear. We anticipate that these gene-specific functional perturbations will be important for understanding molecular mechanisms controlling sea urchin development beyond embryonic stages.
Gene perturbation by targeted genome editing in sea urchins
Targeted genome editing allows gene-specific functional perturbations at the DNA level. Recent advances in genome editing technologies, including ZFNs, TALENs and CRISPR/Cas9, have provided useful tools to generate gene knockouts in sea urchin systems. Based on the use of engineered nucleases brought to specific DNA target sites, all three methods introduce DNA double-stranded breaks (DSBs) followed by DNA repair through homology-directed repair (HDR) or nonhomologous end joining (NHEJ) (Figure 1) . Specific mutations or insertions can be introduced by HDR, in which an exogenous DNA template is required for recombination at the cleavage sites. In the absence of a DNA template, DSBs are typically repaired by the error-prone NHEJ pathway, which uses single-stranded overhangs on the ends of the breaks to guide repair. NHEJ repairs the ends by directly ligating the compatible overhangs using the DNA ligase IV/Xrcc4 complex and is more efficient than HDR. When the overhangs are not compatible, NHEJ relies on other processing factors, such as polymerases and nucleases, to either extend or truncate the overhangs for ligation. Because of these additional processing steps, NHEJ often leads to random insertions or deletions (indels) around cleavage sites. When DSBs occur in the coding region of a gene, these editing events usually cause frameshifts, thus creating functionally inactive gene products. Alternatively, indels occurring in the regulatory sequences, such as enhancers and promoters, can lead to disruption of gene transcription. Both types of cases can be used for loss-of-function studies.
Zinc-finger nucleases
Zinc-finger nuclease (ZFN) genome editing requires a pair of ZFNs, each containing a customized array of zinc-finger binding domains that bind to specific DNA sequences and the nuclease domain of the restriction enzyme FokI (Figure 2A ). An individual array contains three to six zinc-finger repeats, each recognizing a unique DNA triplet, and targets 9-18 bases of DNA sequence [34] . When two ZFNs are both recruited to their binding sites, the two nuclease domains dimerize and generate a DSB. The direction in which two ZFNs are orientated at the target site is important: dimerization occurs only when two ZFNs bind opposite strands of DNA with their C-termini in physical proximity. Because it is zinc-finger binding domains that dictate the DNA-binding ability of ZFNs, screening for zinc-finger arrays that bind desired sequences is crucial. Various strategies have been developed for this purpose, including modular assembly and selection-based methods. The modular assembly approach involves the use of a preselected library of zinc-finger modules and by combining these modules, based on their known specificity, ZFNs are constructed to recognize the DNA target of interest [35] [36] [37] . Either phage display or cellular selection systems are involved in the selection-based approaches [38] [39] [40] .
ZFNs were the first genome editing approach tested in sea urchins [26] . Ochiai et al. have screened a bacterial one-hybrid system using zinc-finger randomized libraries and a mammalian cell culture assay to select for ZFNs targeting the hesC gene in the sea urchin Hemicentrotus pulcherrimus ( Figure 3A) . HesC functions as a repressor for genes responsible for the specification of primary mesenchymal cells (PMCs) [42] . Injections of the ZFNs targeting hesC upregulated the delta gene, which is one of the known target genes of HesC [42] . Sequence analyses revealed that 44% of the polymerase chain reaction (PCR) clones amplified from the injected embryos contained indels at the target site that resulted in frameshifts. The timing of the ZFNmediated mutagenesis was estimated to have occurred between the eight-cell and unhatched blastula stages.
Transcription activator-like effector-based nucleases
Similar to ZFNs, TALENs contain FokI nuclease domains but use naturally existing transcription activator-like effectors (TALEs) in the plant pathogenic bacteria Xanthomonas spp [43] for DNA recognition ( Figure 2B ). The DNA-binding ability of TALEs is mediated by the central domains consisting of multiple repeat units. Each unit contains 31-33 amino acids shared among all units and two variable amino acids called 'repeat variable diresidues' (RVDs) for determining the binding specificity [44, 45] . More than 20 different RVDs have been identified, among which NI, NG, HD and NN are the most commonly used ones that recognize nucleotides A, T, C and G/A, respectively [45, 46] . Following this code, an array of assembled repeats of TALEs can recognize virtually any user-defined sequence.
TALENs have been used to target the sea urchin ETS gene [24] , which plays a pivotal role in the specification of skeletogenic PMCs [47] . TALEN mRNAs targeting ETS caused skeletogenic defects in 12.6% of the injected embryos. Mutagenesis was confirmed at the sequence level, with 51.9% of the PCR clones from the injected embryos showing indels that disrupted the function of the ETS gene. The TALEN-mediated mutations appear to be generated between the unhatched blastula and the mesenchyme blastula stage, a few hours later than the mutations introduced by the ZFNs. However, a significantly smaller amount of the TALEN mRNA compared with that of ZFNs was used in these experiments. Thus, studies with better controlled conditions remain to be conducted to compare the efficiency and effective timing of ZFN-and TALEN-mediated genome editing.
Clustered regularly interspaced short palindromic repeat/clustered regularly interspaced short palindromic repeat-associated protein 9
Unlike the modular protein-based DNA recognition signature of ZFNs and TALENs, the CRISPR/Cas systems use short guide RNAs (gRNAs) to recognize target DNA ( Figure 2C ). The CRISPR/Cas systems were discovered as an immune defense mechanism in bacteria that recognizes and degrades invading DNA [48, 49] . Three major types (I, II and III) and many subtypes of these systems exist in nature, among which the type II CRISPR/Cas9 derived from Streptococcus pyogenes is most commonly used. The CRISPR/Cas9 system is composed of a Cas9 endonuclease and either a CRISPR RNA (crRNA)/trans-activating crRNA (tracrRNA) pair or a chimeric gRNA [50, 51] . The crRNA and the 5 0 end of the gRNA contain a 20-nucleotide guide sequence responsible for the recognition of target sites, while the tracrRNA and the 3 0 end of the gRNA interact with the Cas9 endonuclease. When the Cas9-RNA complexes are introduced into cells, they first scan the genome for a protospaceradjacent motif (PAM), which is NGG for Cas9, and unwind the adjacent DNA for the formation of a heteroduplex composed of the gRNA and its targeted DNA. The endonuclease activity of Cas9 is then triggered and creates a DSB. Because of its RNA-based DNA recognition mechanism, this system provides a simple and scalable approach that empowers researchers to explore the functions of genomic sequences at the systems level. CRISPR/Cas9 technology has recently been successfully used in the sea urchin S. purpuratus. The first study designed six gRNAs targeting the open reading frame of the nodal gene, an upstream factor of the ectoderm GRNs [25] . On injection of sea urchin zygotes with in vitro-synthesized Cas9 mRNA and one of the designed gRNAs, five of the gRNAs were able to induce the expected phenotype in 60-80% of the injected embryos. Analysis of the mutation rates from individual injected embryos revealed that 67-100% of the sequenced clones contained indels at the target sites, indicating that biallelic genomic modifications were introduced. The high efficiency of the CRISPR/Cas9 system is also observed in two recent studies in which multiple gRNAs were combined to target the polyketide synthase 1 (PKS1), the glial cell missing (GCM) or the nanos2 gene [27, 28] . PKS1 encodes an enzyme that is essential for pigment synthesis in sea urchin embryos and is transcriptionally activated by the transcription factor GCM [52] . The effects of CRISPR/Cas9 on both PKS1 and GCM were highly penetrant and generated albino embryos efficiently (>95% albinism in the injected embryos) [28] . Nanos2 encodes a RNAbinding protein and is specifically expressed in the translationally quiescent primordial germ cells of the sea urchin embryo [53] . CRISPR/Cas9 targeting to the nanos2 gene resulted in highefficiency mutations and an increase in translational activity specifically in the primordial germ cells (PGCs) [27] . The high efficiency of the CRISPR/Cas9 system may be attributed to its activity in introducing mutations during early cleavage stages.
Comparison of the three genome editing tools
Choosing a better genome editing approach is essential for successful downstream applications. Here, we compare ZFNs, TALENs and CRISPR/Cas9 for their synthesis strategies and editing efficiencies.
Two modules including DNA-targeting element and DNAcleaving nuclease are required for all three editing tools. Screening for functional ZFNs involves multiple steps, including two rounds of selection, fusion of zinc-finger arrays with a FokI nuclease domain, and verification using single-strand annealing (SSA) assays [41, 54] (Figure 3A ). For TALENs, the assembly of TALE arrays can be technically challenging because of the high sequence similarity among the repeat units. Various methods have been developed to overcome this difficulty, among which the most commonly used approach is the Golden Gate assembly, a strategy based on type IIS restriction enzymes that cleave DNA outside their binding sites [55] . It thus removes the recognition sequences from the assembly to create seamless arrays of orderly assembled repeats ( Figure 3B ). Similar to ZFNs, TALE repeats need to be fused with a FokI domain and tested for efficacy. For the CRISPR/Cas9 system, Cas9 and gRNAs are often synthesized separately. Cas9 mRNA can be transcribed in vitro; alternatively, commercially available Cas9 protein can be used directly. gRNAs can also be transcribed in vitro or customized commercially.
Based on the published results in sea urchins, the genome editing efficiency of the CRISPR/Cas9 system is significantly higher than those of ZFNs and TALENs (Table 1 ). The editing events of CRISPR/Cas9 were also detected earlier than those of ZFNs and TALENs. Considering the efficiency and timing of mutagenesis, CRISPR/Cas9 is a better tool in sea urchins. However, this comparison is drawn from limited studies; thus, a comparison of parallel experiments testing the efficiency of the three methods would be more informative.
Overall, CRISPR/Cas9 is easier to synthesize and offers potentially higher efficiency and earlier timing of mutagenesis. However, one limitation of the CRISPR/Cas9 system is that target sites need to be adjacent to a PAM sequence. The singlebase recognition of TALENs offers greater design flexibility than the triplet-based ZFNs and the PAM-dependent CRISPR/Cas9. Therefore, TALENs would complement the CRISPR/Cas9 system when target sites have to be restricted to a certain region of a gene without PAM sequences.
Other applications of the CRISPR/Cas9 technology
The CRISPR/Cas9 system has become the most widely used genome engineering approach because of its high efficiency, easy design principles and suitability for multiplexing. In addition to disrupting gene functions, modified versions of this system have been developed for generating transgenic animals, investigating functions of noncoding genomes, live imaging of genomes, repressing or activating transcription of genes through epigenetic modification and RNA editing. Many of these applications would greatly benefit studies of sea urchin development and thus await testing and optimization in sea urchin embryos.
Targeted transgenesis
Currently, transgenesis in sea urchins relies on nontargeted gene transfer systems through microinjections of linearized DNA molecules that concatenate and are randomly incorporated into the genome [56, 57] . Using this method, incorporation of transgenes, such as reporter constructs, often occurs during the third or fourth cell division in a fraction of embryonic cells, resulting in mosaic patterns of reporter gene expression [58] . Other gene-transfer techniques, those mediated by I-SceI meganuclease [59, 60] , Minos transposase [61] and pantropic retrovirus [62] , have also been tested in sea urchin embryos. Improved transgenic efficiency (96.5%) was achieved with retroviral transduction of an exogenous reporter construct driven by a ubiquitous Otx enhancer [62] .
Despite the great success in delivering exogenous DNA into sea urchin embryos, the major limitation of the aforementioned transgenic approaches is the lack of control over where the transgenic integration occurs. Targeted transgenesis, in which transgenes integrate at desired locations in the genome, can be achieved through HDR in the presence of a donor template. To date, the only published case of targeted transgenesis in sea urchins used ZFNs to insert a GFP cassette into the coding sequence of the ETS1 gene [63] . By injecting a pair of ZFNs targeting the ETS1 gene and a donor vector containing $1 kb homology arms flanking a GFP cassette, GFP signals were detected in the ETS1-expressing cells. The efficiency was increased to 15% when the activity of DNA ligase IV, a functional element of the NHEJ pathway, was repressed by a dominant-negative construct.
The CRISPR/Cas9 system has been applied in other model organisms for precise gene insertions. Three forms of donor vectors are commonly used: single-stranded oligodeoxynucleotides (ssODNs) with short homology arms (50-80 bp), double-stranded DNA with long homology arms ($800 bp) and double-stranded DNA with short homologous sequences (10-40 bp) flanked by two Cas9 cleavage sites. A double-stranded DNA donor can integrate much longer exogenous DNA sequences such as reporter genes. The precise in-frame insertion of a fluorescence reporter in developmental genes can be used for lineage tracing, deeptissue imaging and cell sorting ( Figure 4A ). The HDR efficiency using ssODNs is generally higher; however, because of its length restriction, its application is limited to shorter sequence modifications, such as introducing point mutations or short functional sites (enzyme recognition sites or the loxP site) ( Figure 4A ). We expect that these approaches will soon be applied in the sea urchin system to improve the efficiency of targeted transgenesis.
Cis-regulatory analysis at genomic loci
The construction of GRN models often requires knowledge of direct regulatory interactions. Current methods used to study and identify these cis-regulatory interactions in sea urchins rely on reporter systems [64] , in which genomic sequences are amplified and measured for their ability to drive reporter expression outside of their genomic context. The CRISPR/Cas9 system has been used to study the functions of regulatory sequences at endogenous genomic loci [65, 66] (Figure 4B ). To delete the entire sequence of a module, two gRNAs targeting both ends of the module need to be delivered simultaneously with Cas9. DSBs at both target sites trigger NHEJ-mediated DNA repair and lead to the genomic deletion of the targeted module. CRISPR/Cas9 can also be used to disrupt putative binding sites to infer direct upstream regulators. This application also offers the opportunity to study chromosomal architectures and how repressors and insulators regulate gene transcription, which would not be possible with reporter assays.
Deletion of specific regulatory modules in the sea urchin genome is potentially feasible. However, because regulatory sequences are usually located in noncoding regions, where polymorphism is generally high, re-sequencing the genomic sequences around potential gRNA target sites may be necessary. Additionally, because the deletion of a DNA fragment requires two gRNAs acting at the same time, choosing two gRNAs with similar efficiencies would increase the chance of fragment deletion instead of creating short indels resulting from actions of a single gRNA.
Transcriptional modulation by CRISPR/dead Cas9
CRISPR interference (CRISPRi) uses a catalytically dead Cas9 (dCas9) to block transcription initiation or elongation [67] . The repressive function of CRISPRi can be further enhanced by fusing dCas9 to the repressive Krü ppel-associated box (KRAB) domain, which promotes epigenetic silencing [68] (Figure 4C) . Similarly, by tethering to transcription activation domains such as VP16/VP64 or P300, dCas9 can be converted into a synthetic transcriptional activator [69, 70] (Figure 4C ). This dCas9-mediated activation (CRISPRa) upregulates the expression of genes from their genomic loci, offering an overexpression tool for studying gain-of-function phenotypes. The position of gRNA targets is critical for this application. A high-throughput assay, in which thousands of gRNAs were designed to target regions around transcription start sites (þ1) of 49 genes, revealed that the highest levels of repression and activation were achieved by targeting the À50 to 300 bp region and the À400 to À50 bp region, respectively [71] .
CRISPR/dCas9 can be combined with other tools to modulate gene expression in a spatially and temporally specific manner. For example, light-activated dCas9-effectors are based on optogenetics, which uses light-induced heterodimerization. By fusing blue-light-sensing system cryptochrome (CRY) and CIB domains to dCas9 and the transcriptional activators VP64 or p65AD, recent studies demonstrated the activation of endogenous genes on illuminating cells with blue light [72, 73] . An inducible system based on rapamycin-dependent dimerization has also been developed for activating endogenous genes [74] . These studies demonstrated that targeted gene regulation could be spatially and temporally controlled in a reversible manner, which is useful for understanding dynamic gene networks.
CRISPR/Cas9 for RNA recognition Native Cas9 acts exclusively on DNA substrates because of its requirement for the PAM sequence. It has been shown that when the PAM is provided in trans as an additional DNA oligonucleotide, Cas9 is able to target single-stranded RNA (ssRNA) [75] (Figure 4D ). Similar to PAM-mediated DNA cleavage, this PAM-presenting oligonucleotide (PAMmer) is able to trigger the site-specific cleavage of ssRNA. Interestingly, this system can tolerate mismatch with ssRNA at the NGG site, as long as additional nucleotides upstream of the NGG are present in the PAMmers to direct the binding. The length of two to eight additional nucleotides has shown to be optimal for specific targeting without compromising the binding affinity and cleavage efficiency [75] . This tolerance of mismatch at the NGG site allows researchers to target any ssRNA without having the constraint of searching for NGG-adjacent gRNA targets. Other RNAbinding CRISPR systems include the CRISPR/Cas type III-B Cmr complex [76] and atypical Cas9 from Francisella novicida [77] . Recently, a Class 2 type VI-A CRISPR/Cas effector C2c2 from Leptotrichia shahii has been demonstrated as the first example of a CRISPR/Cas9 system that exclusively targets RNA [78] . The ability of Cas9 to target RNA allows for the selective alteration of RNA without changing the genomic sequence. In addition to RNA degradation, several potential applications have been discussed for RNA-targeted Cas9 in live cells [79] . For example, by replacing Cas9 with dCas9 fused to a fluorescent protein or biotin, this system allows the visualization of RNA trafficking in living cells and the isolation of the endogenous RNA population [75, 80] .
Conclusion
Functional perturbation is essential to unfold developmental processes into logic maps of regulatory network models. Since the publication of the sea urchin genome in 2006, several GRNs controlling various developmental processes have been established, based mostly on perturbations using regular MOs injected into zygotes. The new technologies described in this review, including vivo-MOs and targeted genome editing, provide flexibility in the temporal and spatial control of functional perturbations in sea urchins. We especially look forward to combine previously established knowledge with the fast-developing CRISPR tools. For example, previously identified tissue-specific enhancers from sea urchins can be used to activate tissue-specific expression of Cas9, resulting in spatial control of genome editing. A photoactivatable Cas9 system can also be used to control the timing of genome editing [81] . New CRISPR endonucleases such as Cpf1 have been discovered and tested in several model organisms [82] . These new CRISPR effectors have provided more possibilities in choosing target sites. We envision that with the development of new technologies, studies on sea urchin development will come into an exciting era.
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Key Points
• Effective perturbation of gene functions by using antisense MOs is the most widely used approach for establishing sea urchin GRNs.
• The modification of morpholinos into membrane permeable vivo-MOs allows gene knockdown at later developmental stages.
• Several genome editing tools have been successfully applied in sea urchins for gene knockout. 
